Next earnings date: 27 Oct 2025
Stryker Corporation – NYSE:SYK
Stryker stock price today
$389.94
+22.82
+6.22%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Stryker stock price monthly change
+8.17%
month
Stryker stock price quarterly change
+8.17%
quarter
Stryker stock price yearly change
+22.77%
year
Stryker key metrics
Market Cap | 138.30B |
Enterprise value | 151.58B |
P/E | 38.97 |
EV/Sales | 6.89 |
EV/EBITDA | 27.65 |
Price/Sales | 6.36 |
Price/Book | 6.94 |
PEG ratio | -1.69 |
EPS | 8.84 |
Revenue | 20.96B |
EBITDA | 5.19B |
Income | 3.36B |
Revenue Q/Q | 9.73% |
Revenue Y/Y | 10.61% |
Profit margin | 16.34% |
Oper. margin | 20.37% |
Gross margin | 62.47% |
EBIT margin | 20.37% |
EBITDA margin | 24.79% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeStryker stock price history
Stryker stock forecast
Stryker financial statements
Average Price Target
$398.3
Potential upside: 2.14%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 4.99B | 738M | 14.77% |
|---|---|---|---|
| Sep 2023 | 4.90B | 692M | 14.1% |
| Dec 2023 | 5.81B | 1.14B | 19.66% |
| Mar 2024 | 5.24B | 788M | 15.03% |
| 2024-10-29 | 2.77 | 2.87 |
|---|
0.65%
Yield TTM
| Payout ratio | 33.4% |
|---|
| 2019 | 0.99% |
|---|---|
| 2020 | 0.94% |
| 2021 | 0.94% |
| 2022 | 1.14% |
| 2023 | 1% |
| Jun 2023 | 37409000000 | 20.04B | 53.59% |
|---|---|---|---|
| Sep 2023 | 38042000000 | 20.13B | 52.93% |
| Dec 2023 | 39912000000 | 21.31B | 53.42% |
| Mar 2024 | 39402000000 | 20.23B | 51.34% |
| Jun 2023 | 688M | -533M | -405M |
|---|---|---|---|
| Sep 2023 | 1.05B | -145M | -422M |
| Dec 2023 | 1.52B | -152M | -286M |
| Mar 2024 | 204M | -408M | -418M |
Stryker alternative data
| Sep 2023 | 51,000 |
|---|---|
| Oct 2023 | 51,000 |
| Nov 2023 | 51,000 |
| Dec 2023 | 51,000 |
| Jan 2024 | 51,000 |
| Feb 2024 | 51,000 |
| Mar 2024 | 52,000 |
| Apr 2024 | 52,000 |
| May 2024 | 52,000 |
| Jun 2024 | 52,000 |
| Jul 2024 | 52,000 |
Stryker other data
74.37%
+0.79%
of SYK is owned by hedge funds
1.61K
+1
284.30M
+2.70M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2024 | 0 | 306315 |
| Mar 2024 | 0 | 7690 |
| May 2024 | 0 | 12007 |
| Aug 2024 | 0 | 210600 |
| Sep 2024 | 0 | 9468 |
| Nov 2024 | 0 | 287827 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | BOEHNLEIN GLENN S officer: VP, Chie.. | Employee Stock Option granted 2/8/2017 (right to buy) | 4,500 | $122.51 | $551,295 | ||
Option | BOEHNLEIN GLENN S officer: VP, Chie.. | Employee Stock Option granted 2/8/2017 (right to buy) | 4,500 | $122.51 | $551,295 | ||
Option | BOEHNLEIN GLENN S officer: VP, Chie.. | Common Stock | 4,500 | $122.51 | $551,295 | ||
Option | BOEHNLEIN GLENN S officer: VP, Chie.. | Common Stock | 4,500 | $122.51 | $551,295 | ||
Sale | STILES SPENCER S officer: Group President | Common Stock | 514 | $391.16 | $201,056 | ||
Option | LOBO KEVIN director, officer.. | Common Stock | 156,890 | $93.06 | $14,600,183 | ||
Option | LOBO KEVIN director, officer.. | Common Stock | 156,890 | $93.06 | $14,600,183 | ||
Sale | LOBO KEVIN director, officer.. | Common Stock | 18,269 | $367.95 | $6,722,079 | ||
Sale | LOBO KEVIN director, officer.. | Common Stock | 18,269 | $367.95 | $6,722,079 | ||
Sale | LOBO KEVIN director, officer.. | Common Stock | 23,178 | $368.58 | $8,542,947 |
| Patent |
|---|
Grant Filling date: 30 Jul 2019 Issue date: 27 Sep 2022 |
Grant Utility: Tissue ablation cannula assembly Filling date: 4 Oct 2018 Issue date: 27 Sep 2022 |
Grant Utility: Stabilization system, implant, and methods for preventing relative motion between sections of tissue Filling date: 20 Apr 2018 Issue date: 27 Sep 2022 |
Grant Filling date: 7 May 2021 Issue date: 20 Sep 2022 |
Grant Filling date: 23 Oct 2018 Issue date: 20 Sep 2022 |
Application Filling date: 23 May 2022 Issue date: 1 Sep 2022 |
Application Filling date: 7 Aug 2020 Issue date: 1 Sep 2022 |
Application Filling date: 30 Jul 2020 Issue date: 1 Sep 2022 |
Application Filling date: 13 May 2022 Issue date: 25 Aug 2022 |
Application Waste Disposal System And Waste Receiver For Receiving And Disposing Of Pharmaceutical Waste Material Filling date: 11 May 2022 Issue date: 25 Aug 2022 |
| Quarter | Transcript |
|---|---|
| Q1 2024 30 Apr 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 30 Jan 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 2 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 3 Aug 2023 | Q2 2023 Earnings Call Transcript |
Globus Medical: Obtaining My Backing Again
LeMaitre Vascular: Scaling Nicely As Global Demand Builds
Baron Opportunity Fund Q1 2025 Top Contributors And Detractors
Smith & Nephew Getting No Credit For Self-Improvement Efforts ... But Should It?
'Physical AI': An All-Robotics Portfolio Sleeve, Preparing For 'Thor'
Boston Scientific Corporation: Solid Financials And Upward Continuation
Zimmer Biomet: Brighter Prospects In H2 2024
Stryker: Rerating Higher
Zimmer Biomet: Weight Loss Drug Concerns Are Overblown
-
What's the price of Stryker stock today?
One share of Stryker stock can currently be purchased for approximately $389.94.
-
When is Stryker's next earnings date?
Stryker Corporation is estimated to report earnings on Monday, 27 Oct 2025.
-
Does Stryker pay dividends?
Yes, Stryker pays dividends and its trailing 12-month yield is 0.65% with 33% payout ratio. The last Stryker stock dividend of $0.7 was paid on 31 Jan 2022.
-
How much money does Stryker make?
Stryker has a market capitalization of 138.30B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 11.11% to 20.5B US dollars. Stryker earned 3.17B US dollars in net income (profit) last year or $2.87 on an earnings per share basis.
-
What is Stryker's stock symbol?
Stryker Corporation is traded on the NYSE under the ticker symbol "SYK".
-
What is Stryker's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Stryker?
Shares of Stryker can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Stryker's key executives?
Stryker's management team includes the following people:
- Mr. Kevin A. Lobo Chairman, Chief Executive Officer & Pres(age: 60, pay: $2,970,000)
- Mr. Glenn S. Boehnlein Vice President & Chief Financial Officer(age: 63, pay: $1,280,000)
- Mr. Viju S. Menon Group Pres of Global Quality & Operations(age: 57, pay: $1,150,000)
- Mr. Robert S. Fletcher Vice President & Chief Legal Officer(age: 54, pay: $895,890)
-
How many employees does Stryker have?
As Jul 2024, Stryker employs 52,000 workers.
-
When Stryker went public?
Stryker Corporation is publicly traded company for more then 45 years since IPO on 17 Mar 1980.
-
What is Stryker's official website?
The official website for Stryker is stryker.com.
-
Where are Stryker's headquarters?
Stryker is headquartered at 2825 Airview Boulevard, Kalamazoo, MI.
-
How can i contact Stryker?
Stryker's mailing address is 2825 Airview Boulevard, Kalamazoo, MI and company can be reached via phone at +269 385 26 00.
-
What is Stryker stock forecast & price target?
Based on 6 Wall Street analysts` predicted price targets for Stryker in the last 12 months, the avarage price target is $398.3. The average price target represents a 2.14% change from the last price of $389.94.
Stryker company profile:
Stryker Corporation
stryker.comExchange:
NYSE
Full time employees:
52,000
Industry:
Medical - Devices
Sector:
Healthcare
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
2825 Airview Boulevard
Kalamazoo, MI 49002
Kalamazoo, MI 49002
CIK: 0000310764
ISIN: US8636671013
CUSIP: 863667101
